Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02WEU
|
|||
| Former ID |
DIB013563
|
|||
| Drug Name |
ApoCell
|
|||
| Synonyms |
Cell-based therpy (iv suspension, inflammatory/autoimmune diseases), Tolarex
Click to Show/Hide
|
|||
| Indication | Autoimmune diabetes [ICD-11: 5A10] | Phase 1/2 | [1] | |
| Company |
Tolarex Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00524784) Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.